Jianli Yin

Shanghai Key Laboratory Of Regulatory Biology
Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

A compact and inducible dCas12f-based CRISPRa platform for programmable in vivo gene activation.

A compact and inducible dCas12f-based CRISPRa platform for programmable in vivo gene activation.

Journal: Nature communications
Published: July 16, 2025

Advances in controllable targeted protein degradation: emerging strategies and mechanisms.

Advances in controllable targeted protein degradation: emerging strategies and mechanisms.

Journal: Science China. Life sciences
Published: July 02, 2025

Translating synthetic gene circuits into the clinic: Challenges, opportunities, and future directions.

Translating synthetic gene circuits into the clinic: Challenges, opportunities, and future directions.

Journal: Cell systems
Published: March 30, 2025

A rapid and efficient red-light-activated Cre recombinase system for genome engineering in mammalian cells and transgenic mice.

A rapid and efficient red-light-activated Cre recombinase system for genome engineering in mammalian cells and transgenic mice.

Journal: Nucleic acids research
Published: March 25, 2025

Designer probiotic-based living drugs for uric acid homeostasis control in hyperuricemic mice and rats.

Designer probiotic-based living drugs for uric acid homeostasis control in hyperuricemic mice and rats.

Journal: Cell reports. Medicine
Published: October 12, 2024

Engineered bacteria for near-infrared light-inducible expression of cancer therapeutics.

Engineered bacteria for near-infrared light-inducible expression of cancer therapeutics.

Journal: Nature cancer
Published: December 18, 2023

Glucose-responsive probiotics for glycaemic modulation in mice and monkeys.

Glucose-responsive probiotics for glycaemic modulation in mice and monkeys.

Journal: Nature
Published: October 16, 2023

A programmable targeted protein-degradation platform for versatile applications in mammalian cells and mice.

A programmable targeted protein-degradation platform for versatile applications in mammalian cells and mice.

Journal: Molecular cell
Published: August 17, 2023

A digital CRISPR-dCas9-based gene remodeling biocomputer programmed by dietary compounds in mammals.

A digital CRISPR-dCas9-based gene remodeling biocomputer programmed by dietary compounds in mammals.

Journal: Cell systems
Published: February 05, 2023

A far-red light-inducible CRISPR-Cas12a platform for remote-controlled genome editing and gene activation.

A far-red light-inducible CRISPR-Cas12a platform for remote-controlled genome editing and gene activation.

Journal: Science advances
Published: December 10, 2021

Engineering genetic devices for in vivo control of therapeutic T cell activity triggered by the dietary molecule resveratrol.

Engineering genetic devices for in vivo control of therapeutic T cell activity triggered by the dietary molecule resveratrol.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 18, 2021

Far-red light-activated human islet-like designer cells enable sustained fine-tuned secretion of insulin for glucose control.

Far-red light-activated human islet-like designer cells enable sustained fine-tuned secretion of insulin for glucose control.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: March 15, 2021
Showing 1-12 of 17

Last Updated: 09/26/2026